LISA SMITH: Open Payments
NPI 1952369043 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,558 in 65 payments from 28 companies in 2025. Trend: 2023 $1,070 · 2024 $902 · 2025 $2,558
Long term medical supply or device loan: $1,180Food & beverage: $1,179Education: $199
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $1,291 |
| Astellas Pharma US Inc | 4 | $256 |
| Merck Sharp & Dohme LLC | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| BeOne Medicines USA, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Kite Pharma, Inc. | 2 | $55 |
| Acrotech Biopharma Inc. | 2 | $54 |
| ABBVIE INC. | 2 | $54 |
| Celgene Corporation | 2 | $48 |
Products named: KISQALI, KEYTRUDA, LIBTAYO, SCEMBLIX, BRUKINSA, Vyloy, BELEODAQ, OPDIVO.
Industry payments across SC — which companies pay providers there.
